RecruitingNot Applicable

Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease

Nepal2,300 participantsStarted 2022-06-01

Plain-language summary

The overall objective is to evaluate the effectiveness of a school-centered primary and secondary prevention program on the prevalence of latent rheumatic heart disease among schoolchildren in Nepal, and to investigate the role of socioeconomic and environmental factors in the development and progression of rheumatic heart disease.

Who can participate

Age range5 Years – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 5-16 years * Attending Tulsi Secondary Boarding School in Tulsipur, Nepal. Exclusion Criteria: * Children / primary caregivers not providing informed consent to participate * Children not attending Tulsi Secondary Boarding School in Tulsipur.

What they're measuring

Prevalence of definite or borderline Rheumatic Heart Disease

Timeframe: 4 years

Trial details

NCT IDNCT05504928

SponsorInsel Gruppe AG, University Hospital Bern

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-01

Contact for this trial

Thomas Pilgrim, Prof. Dr.

0041316325000 kardio.studien@insel.ch

View on ClinicalTrials.gov More Rheumatic Heart Disease trials